These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24430674)

  • 21. Small-molecule quinolinol inhibitor identified provides protection against BoNT/A in mice.
    Singh P; Singh MK; Chaudhary D; Chauhan V; Bharadwaj P; Pandey A; Upadhyay N; Dhaked RK
    PLoS One; 2012; 7(10):e47110. PubMed ID: 23071727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of inhibition of botulinum neurotoxin type A light chain by two quinolinol compounds.
    Minnow YV; Goldberg R; Tummalapalli SR; Rotella DP; Goodey NM
    Arch Biochem Biophys; 2017 Mar; 618():15-22. PubMed ID: 28137423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of biologically active botulinum neurotoxin--A in serum using high-throughput FRET-assay.
    Joshi SG
    J Pharmacol Toxicol Methods; 2012 Jan; 65(1):8-12. PubMed ID: 22178409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B.
    Fan Y; Dong J; Lou J; Wen W; Conrad F; Geren IN; Garcia-Rodriguez C; Smith TJ; Smith LA; Ho M; Pires-Alves M; Wilson BA; Marks JD
    Toxins (Basel); 2015 Aug; 7(9):3405-23. PubMed ID: 26343720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuronal targeting, internalization, and biological activity of a recombinant atoxic derivative of botulinum neurotoxin A.
    Pellett S; Tepp WH; Stanker LH; Band PA; Johnson EA; Ichtchenko K
    Biochem Biophys Res Commun; 2011 Feb; 405(4):673-7. PubMed ID: 21284937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A.
    Roxas-Duncan V; Enyedy I; Montgomery VA; Eccard VS; Carrington MA; Lai H; Gul N; Yang DC; Smith LA
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3478-86. PubMed ID: 19528275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors.
    Li B; Pai R; Cardinale SC; Butler MM; Peet NP; Moir DT; Bavari S; Bowlin TL
    J Med Chem; 2010 Mar; 53(5):2264-76. PubMed ID: 20155918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary cultures of embryonic chicken neurons for sensitive cell-based assay of botulinum neurotoxin: implications for therapeutic discovery.
    Stahl AM; Ruthel G; Torres-Melendez E; Kenny TA; Panchal RG; Bavari S
    J Biomol Screen; 2007 Apr; 12(3):370-7. PubMed ID: 17332092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular Protection of SNAP-25 against Botulinum Neurotoxin/A: Inhibition of Thioredoxin Reductase through a Suicide Substrate Mechanism.
    Seki H; Xue S; Pellett S; Šilhár P; Johnson EA; Janda KD
    J Am Chem Soc; 2016 May; 138(17):5568-75. PubMed ID: 27070533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors.
    Li B; Cardinale SC; Butler MM; Pai R; Nuss JE; Peet NP; Bavari S; Bowlin TL
    Bioorg Med Chem; 2011 Dec; 19(24):7338-48. PubMed ID: 22082667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depolarization after resonance energy transfer (DARET): a sensitive fluorescence-based assay for botulinum neurotoxin protease activity.
    Gilmore MA; Williams D; Okawa Y; Holguin B; James NG; Ross JA; Roger Aoki K; Jameson DM; Steward LE
    Anal Biochem; 2011 Jun; 413(1):36-42. PubMed ID: 21300022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An efficient drug delivery vehicle for botulism countermeasure.
    Zhang P; Ray R; Singh BR; Li D; Adler M; Ray P
    BMC Pharmacol; 2009 Oct; 9():12. PubMed ID: 19860869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-nociceptive effect of a conjugate of substance P and light chain of botulinum neurotoxin type A.
    Mustafa G; Anderson EM; Bokrand-Donatelli Y; Neubert JK; Caudle RM
    Pain; 2013 Nov; 154(11):2547-2553. PubMed ID: 23933181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro potency determination of botulinum neurotoxin serotype A based on its receptor-binding and proteolytic characteristics.
    Behrensdorf-Nicol HA; Wild E; Bonifas U; Klimek J; Hanschmann KM; Krämer B; Kegel B
    Toxicol In Vitro; 2018 Dec; 53():80-88. PubMed ID: 30016653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple, rapid and sensitive FRET assay for botulinum neurotoxin serotype B detection.
    Guo J; Xu C; Li X; Chen S
    PLoS One; 2014; 9(12):e114124. PubMed ID: 25437190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computer-aided identification, synthesis, and biological evaluation of novel inhibitors for botulinum neurotoxin serotype A.
    Teng YH; Berger WT; Nesbitt NM; Kumar K; Balius TE; Rizzo RC; Tonge PJ; Ojima I; Swaminathan S
    Bioorg Med Chem; 2015 Sep; 23(17):5489-95. PubMed ID: 26275678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of library of betulin derivatives against the botulinum neurotoxin A protease.
    Šilhár P; Alakurtti S; Čapková K; Xiaochuan F; Shoemaker CB; Yli-Kauhaluoma J; Janda KD
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2229-31. PubMed ID: 21421315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a delivery vehicle for intracellular transport of botulinum neurotoxin antagonists.
    Goodnough MC; Oyler G; Fishman PS; Johnson EA; Neale EA; Keller JE; Tepp WH; Clark M; Hartz S; Adler M
    FEBS Lett; 2002 Feb; 513(2-3):163-8. PubMed ID: 11904143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A graphene oxide based fluorescence resonance energy transfer (FRET) biosensor for ultrasensitive detection of botulinum neurotoxin A (BoNT/A) enzymatic activity.
    Shi J; Guo J; Bai G; Chan C; Liu X; Ye W; Hao J; Chen S; Yang M
    Biosens Bioelectron; 2015 Mar; 65():238-44. PubMed ID: 25461164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system.
    Tsai YC; Maditz R; Kuo CL; Fishman PS; Shoemaker CB; Oyler GA; Weissman AM
    Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16554-9. PubMed ID: 20823219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.